Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes
Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously repor...
Saved in:
Published in | International journal of molecular sciences Vol. 26; no. 2; p. 637 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
14.01.2025
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 1422-0067 1661-6596 1422-0067 |
DOI | 10.3390/ijms26020637 |
Cover
Loading…
Abstract | Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes. |
---|---|
AbstractList | Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes. Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes. |
Audience | Academic |
Author | Alsharhan, Mouza Al Awadi, Fatheya Farooqi, Muhammad Tawfik, Abdel Rahman Dsouza, Stafny Ahmed, Fayha Alkhnbashi, Omer Abdul, Fatima Faraji, Hanan Bayoumi, Riad Hassanein, Mohammed Khyriem, Costerwell Sulaiman, Fatima Khamis, Amar Hassan |
AuthorAffiliation | 2 Center for Applied and Translational Genomics, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; omer.alkhnbashi@dubaihealth.ae 6 Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; abdel.tawfik@dubaihealth.ae (A.R.T.); amar.hassan@dubaihealth.ae (A.H.K.) 1 College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; fatima.sulaiman@students.mbru.ac.ae (F.S.); costerwell.khyriem@dubaihealth.ae (C.K.); stafny.dsouza@dubaihealth.ae (S.D.); fatima.abdul@dubaihealth.ae (F.A.); hanan.faraji@students.mbru.ac.ae (H.F.) 5 Pathology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; faaahmed@dubaihealth.ae (F.A.); maalsharhan@dubaihealth.ae (M.A.) 3 Dubai Diabetes Center, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; mhfaro |
AuthorAffiliation_xml | – name: 4 Endocrinology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; ffalawadi@dubaihealth.ae (F.A.A.); mmhassanein@dubaihealth.ae (M.H.) – name: 1 College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; fatima.sulaiman@students.mbru.ac.ae (F.S.); costerwell.khyriem@dubaihealth.ae (C.K.); stafny.dsouza@dubaihealth.ae (S.D.); fatima.abdul@dubaihealth.ae (F.A.); hanan.faraji@students.mbru.ac.ae (H.F.) – name: 2 Center for Applied and Translational Genomics, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; omer.alkhnbashi@dubaihealth.ae – name: 5 Pathology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; faaahmed@dubaihealth.ae (F.A.); maalsharhan@dubaihealth.ae (M.A.) – name: 3 Dubai Diabetes Center, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; mhfarooqi@dubaihealth.ae – name: 6 Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; abdel.tawfik@dubaihealth.ae (A.R.T.); amar.hassan@dubaihealth.ae (A.H.K.) |
Author_xml | – sequence: 1 givenname: Fatima surname: Sulaiman fullname: Sulaiman, Fatima – sequence: 2 givenname: Costerwell orcidid: 0000-0003-2078-2532 surname: Khyriem fullname: Khyriem, Costerwell – sequence: 3 givenname: Stafny orcidid: 0000-0001-5618-6930 surname: Dsouza fullname: Dsouza, Stafny – sequence: 4 givenname: Fatima surname: Abdul fullname: Abdul, Fatima – sequence: 5 givenname: Omer orcidid: 0000-0001-8088-590X surname: Alkhnbashi fullname: Alkhnbashi, Omer – sequence: 6 givenname: Hanan surname: Faraji fullname: Faraji, Hanan – sequence: 7 givenname: Muhammad orcidid: 0000-0001-6489-3715 surname: Farooqi fullname: Farooqi, Muhammad – sequence: 8 givenname: Fatheya orcidid: 0000-0001-8911-866X surname: Al Awadi fullname: Al Awadi, Fatheya – sequence: 9 givenname: Mohammed surname: Hassanein fullname: Hassanein, Mohammed – sequence: 10 givenname: Fayha orcidid: 0009-0005-2542-9959 surname: Ahmed fullname: Ahmed, Fayha – sequence: 11 givenname: Mouza surname: Alsharhan fullname: Alsharhan, Mouza – sequence: 12 givenname: Abdel Rahman surname: Tawfik fullname: Tawfik, Abdel Rahman – sequence: 13 givenname: Amar Hassan orcidid: 0000-0002-8518-3066 surname: Khamis fullname: Khamis, Amar Hassan – sequence: 14 givenname: Riad orcidid: 0000-0001-8177-8129 surname: Bayoumi fullname: Bayoumi, Riad |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39859351$$D View this record in MEDLINE/PubMed |
BookMark | eNptks1PHCEYxkmj8aveem4m8eKha19gGODUbLa21RhNqj0ThoWVzQysMNNE__qy9aNrYzjw5uHHA-_HPtoKMViEPmA4oVTCZ7_sM2mAQEP5O7SHa0ImAA3f2oh30X7OSwBCCZM7aJdKwSRleA-dz2510mawyT_4sKhmPpmx08M67r1J8efltLr2i6CHMdlcRVfd3K9sRaqvXrd2KNL12A5Fyu_RttNdtodP-wH69e30ZvZjcnH1_Ww2vZiYmvJhIhg1ILSxsm25kY2khmNuKKFO4EZzPq-Z0AyDlUS0kjvcQktYU1Pi9NxxeoC-PPquxra3c2PDkHSnVsn3Ot2rqL16fRL8rVrE3wpj3jQgoTgcPzmkeDfaPKjeZ2O7Tgcbx6woZlIAJgIX9Og_dBnHFEp-fykGgLn8Ry10Z5UPLpaHzdpUTUWpOcZ1vf74yRtUWXNbSl266nzRX134uJnpS4rP7SvAp0egNCrnZN0LgkGtp0NtTgf9AxRuqkk |
Cites_doi | 10.1002/jev2.12055 10.51847/SKWTZqgB22 10.3390/diagnostics12102275 10.2337/dc16-1354 10.2337/db18-0470 10.1093/nar/gkae456 10.3389/fendo.2022.888948 10.3892/mmr.2017.6239 10.1016/j.cels.2019.03.004 10.1186/1755-8794-3-21 10.3389/fendo.2022.937089 10.1186/s12916-017-0901-x 10.1093/nar/gky1141 10.1016/j.trsl.2022.03.008 10.1093/nar/gkac1072 10.1186/1471-2105-12-480 10.1126/scitranslmed.aaa9364 10.1210/er.2019-00088 10.1007/s00125-022-05769-4 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622 10.1186/s12889-023-16540-8 10.1016/j.cca.2013.05.021 10.1007/s00125-012-2539-8 10.1101/319509 10.1371/journal.pone.0304036 10.1016/j.bbrc.2018.02.129 10.1111/iwj.14007 10.1093/bioinformatics/btv494 10.4239/wjd.v15.i2.260 10.1155/2023/9663320 10.1038/srep44986 10.1371/journal.pone.0041561 10.1159/000512428 10.1002/dmrr.3005 10.1016/j.xcrm.2021.100477 10.1089/nat.2018.0763 10.1007/s11033-016-4043-6 10.7754/Clin.Lab.2018.181113 10.2337/db17-0141 10.1093/nar/gkp427 10.7150/thno.23334 10.3390/jcm9041220 10.1038/s41587-023-01767-y 10.1038/s41598-019-43793-4 10.1186/1423-0127-20-72 10.1093/nar/gkr688 10.1093/nar/gkac963 10.1186/1755-8794-2-54 10.2337/dc15-S005 10.1002/iub.1970 10.1016/j.ncrna.2024.07.001 10.1515/bmc-2017-0024 10.1016/j.trsl.2018.09.006 10.4239/wjd.v10.i4.241 10.1007/s00125-015-3510-2 10.3389/fendo.2023.1192629 10.1038/nrendo.2009.102 10.1136/bmjdrc-2020-001506 10.1371/journal.pone.0111537 10.1038/nrendo.2013.86 10.1007/s00125-017-4210-x 10.1016/j.diabres.2021.109119 10.3390/ijms18030456 10.3390/ijms21176275 10.1093/nar/gkaa467 10.7754/Clin.Lab.2021.210447 10.1016/S2213-8587(18)30051-2 10.1080/09168451.2015.1107460 10.3390/ijms24032964 10.1016/j.humgen.2023.201191 10.5001/omj.2014.11 10.4238/gmr.15027259 10.1186/s43141-022-00348-x 10.1016/j.tem.2018.03.019 10.1038/ncb2211 10.1371/journal.pone.0128372 10.3390/jcm9072184 10.1007/s00125-019-4909-y 10.4103/ijem.IJEM_162_18 10.1186/s40364-015-0047-y 10.1093/bib/bbac222 10.1186/s12859-019-3105-x 10.2337/diab.43.11.1271 10.1093/cvr/cvq010 10.7150/ijms.10001 10.1111/jcmm.14182 10.1007/s00592-018-1149-4 10.3390/diagnostics11060949 10.1007/978-3-319-24277-4_9 10.1038/s41588-021-00948-2 10.1007/s11010-014-2170-8 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2025 MDPI AG 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 by the authors. 2025 |
Copyright_xml | – notice: COPYRIGHT 2025 MDPI AG – notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 by the authors. 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.3390/ijms26020637 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | PMC11766090 A832511447 39859351 10_3390_ijms26020637 |
Genre | Journal Article |
GeographicLocations | United Arab Emirates Middle East |
GeographicLocations_xml | – name: United Arab Emirates – name: Middle East |
GrantInformation_xml | – fundername: Sandooq Al Watan grantid: This research was funded by the COLLEGE OF MEDICINE, MOHAMMED BIN RASHID UNI-VERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU), grant Number: MBRU-CM-RG2021-09 and SANDOOQ AL WATAN LLC, grant number: SWARD-F22-013 to R.B. The APC was funded by MBRU, Ph.D. gr – fundername: SANDOOQ AL WATAN LLC grantid: SWARD-F22-013 – fundername: MBRU grantid: PhDBMS21 – fundername: COLLEGE OF MEDICINE, MOHAMMED BIN RASHID UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU) grantid: MBRU-CM-RG2021-09 |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c437t-853c08ace9bb7c9693c717c323f816a77d458a510e928b97f1b0b256432fadf73 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Thu Aug 21 18:40:37 EDT 2025 Thu Jul 10 23:40:15 EDT 2025 Fri Jul 25 22:26:46 EDT 2025 Tue Jun 17 21:58:24 EDT 2025 Tue Jun 10 20:58:59 EDT 2025 Tue May 06 01:31:52 EDT 2025 Tue Jul 01 02:40:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Type 2 diabetes T2D subtypes insulin resistance circulating microRNA pathophysiology |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c437t-853c08ace9bb7c9693c717c323f816a77d458a510e928b97f1b0b256432fadf73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2078-2532 0000-0002-8518-3066 0000-0001-8088-590X 0000-0001-8911-866X 0009-0005-2542-9959 0000-0001-8177-8129 0000-0001-5618-6930 0000-0001-6489-3715 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms26020637 |
PMID | 39859351 |
PQID | 3159500179 |
PQPubID | 2032341 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11766090 proquest_miscellaneous_3159801281 proquest_journals_3159500179 gale_infotracmisc_A832511447 gale_infotracacademiconefile_A832511447 pubmed_primary_39859351 crossref_primary_10_3390_ijms26020637 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20250114 |
PublicationDateYYYYMMDD | 2025-01-14 |
PublicationDate_xml | – month: 1 year: 2025 text: 20250114 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2025 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | ref_50 ref_93 Pearson (ref_9) 2019; 62 Anjana (ref_11) 2020; 8 Bijkerk (ref_26) 2019; 29 Hotamisligil (ref_75) 1994; 43 Stidsen (ref_12) 2018; 34 Bodenhofer (ref_92) 2015; 31 Libera (ref_40) 2018; 8 Camargo (ref_45) 2018; 50 Ahlqvist (ref_14) 2018; 6 Zhou (ref_41) 2012; 55 ref_58 ref_57 ref_56 Li (ref_46) 2018; 29 Udler (ref_15) 2019; 40 ref_54 Pokharel (ref_68) 2024; 9 ref_52 Li (ref_13) 2015; 7 Shah (ref_28) 2017; 40 Gluckman (ref_23) 2009; 5 MacKowiak (ref_80) 2012; 40 Aravinda (ref_6) 2019; 10 ref_16 Yan (ref_43) 2014; 397 Dwivedi (ref_17) 2021; 53 Xihua (ref_61) 2019; 205 Xia (ref_51) 2022; 68 Micheloni (ref_21) 2018; 55 ref_60 Grieco (ref_32) 2022; 247 Lu (ref_64) 2010; 86 Gautam (ref_30) 2016; 43 Kozomara (ref_82) 2019; 47 ref_65 ref_20 Elizarraras (ref_90) 2024; 52 Tian (ref_76) 2018; 73 ref_29 Woodhouse (ref_79) 2014; 29 Shaker (ref_33) 2019; 71 Song (ref_62) 2018; 497 Sun (ref_55) 2023; 20 Deutsch (ref_18) 2022; 65 Sun (ref_2) 2022; 183 ref_71 Guay (ref_31) 2013; 9 Hao (ref_87) 2024; 42 Sucharita (ref_25) 2018; 22 ref_36 ref_35 ref_34 ref_78 ref_77 ref_74 Hassanein (ref_5) 2020; 26 Zhu (ref_24) 2015; 58 McCarthy (ref_10) 2017; 60 Chang (ref_88) 2020; 48 Brorsson (ref_19) 2022; 3 ref_39 Massart (ref_48) 2017; 66 ref_37 Nassar (ref_81) 2023; 51 Rozowsky (ref_85) 2019; 8 Yang (ref_59) 2019; 65 ref_83 Kanehisa (ref_91) 2023; 51 Wu (ref_8) 2014; 11 Ghai (ref_49) 2019; 23 Abbas (ref_73) 2023; 37 ref_89 ref_44 Li (ref_27) 2021; 10 ref_42 ref_86 Jordan (ref_63) 2011; 13 Guo (ref_47) 2023; 2023 ref_84 ref_1 Morales (ref_22) 2017; 8 He (ref_53) 2024; 15 ref_3 Chen (ref_72) 2009; 37 Yamada (ref_70) 2013; 424 Yang (ref_66) 2017; 15 Mohamed (ref_67) 2022; 13 ref_4 Ding (ref_69) 2016; 80 ref_7 Katayama (ref_38) 2019; 68 |
References_xml | – volume: 10 start-page: e12055 year: 2021 ident: ref_27 article-title: Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family publication-title: J. Extracell. Vesicles doi: 10.1002/jev2.12055 – volume: 13 start-page: 137 year: 2022 ident: ref_67 article-title: MicroRNA-224 Up-regulation: A Risk for Complications in Type 2 Diabetes Mellitus Egyptian Patients publication-title: Pharmacophore doi: 10.51847/SKWTZqgB22 – ident: ref_52 doi: 10.3390/diagnostics12102275 – volume: 40 start-page: 546 year: 2017 ident: ref_28 article-title: Extracellular RNAs are associated with insulin resistance and metabolic phenotypes publication-title: Diabetes Care doi: 10.2337/dc16-1354 – volume: 68 start-page: 515 year: 2019 ident: ref_38 article-title: Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle publication-title: Diabetes doi: 10.2337/db18-0470 – volume: 52 start-page: W415 year: 2024 ident: ref_90 article-title: WebGestalt 2024: Faster gene set analysis and new support for metabolomics and multi-omics publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkae456 – ident: ref_56 doi: 10.3389/fendo.2022.888948 – volume: 15 start-page: 2143 year: 2017 ident: ref_66 article-title: Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2017.6239 – volume: 8 start-page: 352 year: 2019 ident: ref_85 article-title: exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling publication-title: Cell Syst. doi: 10.1016/j.cels.2019.03.004 – ident: ref_86 doi: 10.1186/1755-8794-3-21 – ident: ref_57 doi: 10.3389/fendo.2022.937089 – ident: ref_7 doi: 10.1186/s12916-017-0901-x – volume: 47 start-page: D155 year: 2019 ident: ref_82 article-title: miRBase: From microRNA sequences to function publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky1141 – volume: 247 start-page: 137 year: 2022 ident: ref_32 article-title: Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside publication-title: Transl. Res. doi: 10.1016/j.trsl.2022.03.008 – volume: 51 start-page: D1188 year: 2023 ident: ref_81 article-title: The UCSC Genome Browser database: 2023 update publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac1072 – ident: ref_83 doi: 10.1186/1471-2105-12-480 – volume: 7 start-page: 311ra174 year: 2015 ident: ref_13 article-title: Identification of type 2 diabetes subgroups through topological analysis of patient similarity publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaa9364 – volume: 40 start-page: 1500 year: 2019 ident: ref_15 article-title: Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine publication-title: Endocr. Rev. doi: 10.1210/er.2019-00088 – volume: 65 start-page: 1758 year: 2022 ident: ref_18 article-title: Phenotypic and genetic classification of diabetes publication-title: Diabetologia doi: 10.1007/s00125-022-05769-4 – ident: ref_34 doi: 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622 – ident: ref_4 doi: 10.1186/s12889-023-16540-8 – volume: 424 start-page: 99 year: 2013 ident: ref_70 article-title: Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2013.05.021 – volume: 55 start-page: 2032 year: 2012 ident: ref_41 article-title: Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity publication-title: Diabetologia doi: 10.1007/s00125-012-2539-8 – ident: ref_16 doi: 10.1101/319509 – ident: ref_20 doi: 10.1371/journal.pone.0304036 – volume: 497 start-page: 667 year: 2018 ident: ref_62 article-title: MiR-29 family members interact with SPARC to regulate glucose metabolism publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.02.129 – volume: 20 start-page: 1525 year: 2023 ident: ref_55 article-title: A gene chip study suggests that miR-17-3p is associated with diabetic foot ulcers publication-title: Int. Wound J. doi: 10.1111/iwj.14007 – volume: 31 start-page: 3997 year: 2015 ident: ref_92 article-title: Msa: An R package for multiple sequence alignment publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv494 – volume: 15 start-page: 260 year: 2024 ident: ref_53 article-title: Long noncoding RNA protein-disulfide isomerase-associated 3 regulated high glucose-induced podocyte apoptosis in diabetic nephropathy through targeting miR-139-3p publication-title: World J. Diabetes doi: 10.4239/wjd.v15.i2.260 – volume: 2023 start-page: 9663320 year: 2023 ident: ref_47 article-title: Expression and Clinical Significance of Plasma miR-223 in Patients with Diabetic Nephropathy publication-title: Int. J. Endocrinol. doi: 10.1155/2023/9663320 – ident: ref_50 doi: 10.1038/srep44986 – ident: ref_29 doi: 10.1371/journal.pone.0041561 – volume: 26 start-page: 164 year: 2020 ident: ref_5 article-title: Prevalence of Diabetes and Associated Health Risk Factors among Adults in Dubai, United Arab Emirates: Results from Dubai Household Survey 2019 publication-title: Dubai Diabetes Endocrinol. J. doi: 10.1159/000512428 – volume: 34 start-page: e3005 year: 2018 ident: ref_12 article-title: Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool publication-title: Diabetes Metab. Res. Rev. doi: 10.1002/dmrr.3005 – volume: 3 start-page: 100477 year: 2022 ident: ref_19 article-title: Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100477 – volume: 29 start-page: 67 year: 2019 ident: ref_26 article-title: In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion publication-title: Nucleic Acid Ther. doi: 10.1089/nat.2018.0763 – volume: 43 start-page: 1165 year: 2016 ident: ref_30 article-title: Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods publication-title: Mol. Biol. Rep. doi: 10.1007/s11033-016-4043-6 – volume: 65 start-page: 1015 year: 2019 ident: ref_59 article-title: Peripheral blood miR-937 may serve as a biomarker for metabolic disorders by targeting AMPKα publication-title: Clin. Lab. doi: 10.7754/Clin.Lab.2018.181113 – volume: 66 start-page: 1807 year: 2017 ident: ref_48 article-title: Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle publication-title: Diabetes doi: 10.2337/db17-0141 – volume: 73 start-page: 477 year: 2018 ident: ref_76 article-title: MiR-486-5p regulates pancreatic β cell function in type 2 diabetes mellitus by targeting PTEN and FOXO1 publication-title: Die Pharm.-Int. J. Pharm. Sci. – volume: 37 start-page: W305 year: 2009 ident: ref_72 article-title: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkp427 – volume: 8 start-page: 3874 year: 2018 ident: ref_40 article-title: Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes publication-title: Theranostics doi: 10.7150/thno.23334 – ident: ref_54 doi: 10.3390/jcm9041220 – volume: 42 start-page: 293 year: 2024 ident: ref_87 article-title: Dictionary learning for integrative, multimodal and scalable single-cell analysis publication-title: Nat. Biotechnol. doi: 10.1038/s41587-023-01767-y – ident: ref_77 doi: 10.1038/s41598-019-43793-4 – ident: ref_71 doi: 10.1186/1423-0127-20-72 – volume: 40 start-page: 37 year: 2012 ident: ref_80 article-title: miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkr688 – volume: 51 start-page: D587 year: 2023 ident: ref_91 article-title: KEGG for taxonomy-based analysis of pathways and genomes publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac963 – ident: ref_65 doi: 10.1186/1755-8794-2-54 – ident: ref_78 doi: 10.2337/dc15-S005 – volume: 71 start-page: 310 year: 2019 ident: ref_33 article-title: Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy publication-title: IUBMB Life doi: 10.1002/iub.1970 – volume: 9 start-page: 1324 year: 2024 ident: ref_68 article-title: Evaluation of circulating plasma miR-9, miR-29a, miR-192, and miR-375 as potential biomarkers for predicting prediabetes and type 2 diabetes in Nepali adult population publication-title: Noncoding RNA Res. doi: 10.1016/j.ncrna.2024.07.001 – volume: 8 start-page: 203 year: 2017 ident: ref_22 article-title: Epigenetic regulation mechanisms of microRNA expression publication-title: Biomol. Concepts doi: 10.1515/bmc-2017-0024 – volume: 205 start-page: 33 year: 2019 ident: ref_61 article-title: Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor publication-title: Transl. Res. doi: 10.1016/j.trsl.2018.09.006 – volume: 10 start-page: 241 year: 2019 ident: ref_6 article-title: Risk factors in patients with type 2 diabetes in Bengaluru: A retrospective study publication-title: World J. Diabetes doi: 10.4239/wjd.v10.i4.241 – volume: 58 start-page: 900 year: 2015 ident: ref_24 article-title: Identification of microRNA biomarkers in type 2 diabetes: A meta-analysis of controlled profiling studies publication-title: Diabetologia doi: 10.1007/s00125-015-3510-2 – ident: ref_3 doi: 10.3389/fendo.2023.1192629 – volume: 5 start-page: 401 year: 2009 ident: ref_23 article-title: Epigenetic mechanisms that underpin metabolic and cardiovascular diseases publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2009.102 – volume: 50 start-page: 12 year: 2018 ident: ref_45 article-title: A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: From the CORDIOPREV study publication-title: Exp. Mol. Med. – volume: 8 start-page: e001506 year: 2020 ident: ref_11 article-title: Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: A data-driven cluster analysis: The INSPIRED study publication-title: BMJ Open Diabetes Res. Care doi: 10.1136/bmjdrc-2020-001506 – ident: ref_74 doi: 10.1371/journal.pone.0111537 – volume: 9 start-page: 513 year: 2013 ident: ref_31 article-title: Circulating microRNAs as novel biomarkers for diabetes mellitus publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2013.86 – volume: 60 start-page: 793 year: 2017 ident: ref_10 article-title: Painting a new picture of personalised medicine for diabetes publication-title: Diabetologia doi: 10.1007/s00125-017-4210-x – volume: 183 start-page: 109119 year: 2022 ident: ref_2 article-title: IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2021.109119 – ident: ref_37 doi: 10.3390/ijms18030456 – ident: ref_1 doi: 10.3390/ijms21176275 – volume: 48 start-page: W244 year: 2020 ident: ref_88 article-title: miRNet 2.0: Network-based visual analytics for miRNA functional analysis and systems biology publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkaa467 – volume: 68 start-page: 689 year: 2022 ident: ref_51 article-title: Plasma Levels and Diagnostic Significance of miR-335-3p and EGFR in Diabetic Retinopathy publication-title: Clin. Lab. doi: 10.7754/Clin.Lab.2021.210447 – volume: 6 start-page: 361 year: 2018 ident: ref_14 article-title: Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables publication-title: Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(18)30051-2 – volume: 80 start-page: 461 year: 2016 ident: ref_69 article-title: Identification of the differential expression of serum microRNA in type 2 diabetes publication-title: Biosci. Biotechnol. Biochem. doi: 10.1080/09168451.2015.1107460 – ident: ref_60 doi: 10.3390/ijms24032964 – volume: 37 start-page: 201191 year: 2023 ident: ref_73 article-title: Expression of microRNAs 30, 451, 130, and 378 and its relationship to type 1 diabetes mellitus in Egyptian children publication-title: Hum. Gene doi: 10.1016/j.humgen.2023.201191 – volume: 29 start-page: 51 year: 2014 ident: ref_79 article-title: Familial Clustering of Type 2 Diabetes among Omanis publication-title: Oman Med. J. doi: 10.5001/omj.2014.11 – ident: ref_36 doi: 10.4238/gmr.15027259 – ident: ref_39 doi: 10.1186/s43141-022-00348-x – volume: 29 start-page: 380 year: 2018 ident: ref_46 article-title: A Novel Regulator of Type II Diabetes: MicroRNA-143 publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2018.03.019 – volume: 13 start-page: 434 year: 2011 ident: ref_63 article-title: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism publication-title: Nat. Cell. Biol. doi: 10.1038/ncb2211 – ident: ref_44 doi: 10.1371/journal.pone.0128372 – ident: ref_58 doi: 10.3390/jcm9072184 – volume: 62 start-page: 1107 year: 2019 ident: ref_9 article-title: Type 2 diabetes: A multifaceted disease publication-title: Diabetologia doi: 10.1007/s00125-019-4909-y – volume: 22 start-page: 770 year: 2018 ident: ref_25 article-title: The Role of Circulating MicroRNA in the Regulation of Beta Cell Function and Insulin Resistance among Indians with Type 2 Diabetes publication-title: Indian J. Endocrinol. Metab. doi: 10.4103/ijem.IJEM_162_18 – ident: ref_42 doi: 10.1186/s40364-015-0047-y – ident: ref_93 doi: 10.1093/bib/bbac222 – ident: ref_89 doi: 10.1186/s12859-019-3105-x – volume: 43 start-page: 1271 year: 1994 ident: ref_75 article-title: Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link publication-title: Diabetes doi: 10.2337/diab.43.11.1271 – volume: 86 start-page: 410 year: 2010 ident: ref_64 article-title: MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvq010 – volume: 11 start-page: 1185 year: 2014 ident: ref_8 article-title: Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention publication-title: Int. J. Med. Sci. doi: 10.7150/ijms.10001 – volume: 23 start-page: 2753 year: 2019 ident: ref_49 article-title: Circulating RNAs as predictive markers for the progression of type 2 diabetes publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.14182 – volume: 55 start-page: 989 year: 2018 ident: ref_21 article-title: Novel insights into the regulation of miRNA transcriptional control: Implications for T2D and related complications publication-title: Acta Diabetol. doi: 10.1007/s00592-018-1149-4 – ident: ref_35 doi: 10.3390/diagnostics11060949 – ident: ref_84 doi: 10.1007/978-3-319-24277-4_9 – volume: 53 start-page: 1534 year: 2021 ident: ref_17 article-title: Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes publication-title: Nat. Genet. doi: 10.1038/s41588-021-00948-2 – volume: 397 start-page: 45 year: 2014 ident: ref_43 article-title: MiR-199a is overexpressed in plasma of type 2 diabetes patients which contributes to type 2 diabetes by targeting GLUT4 publication-title: Mol. Cell Biochem. doi: 10.1007/s11010-014-2170-8 |
SSID | ssj0023259 |
Score | 2.4279854 |
Snippet | Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 637 |
SubjectTerms | Adult Aged Analysis Biomarkers - blood Body mass index Case-Control Studies Circulating MicroRNA - blood Circulating MicroRNA - genetics Cluster analysis Computational Biology - methods Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - classification Diabetes Mellitus, Type 2 - genetics Disease DNA methylation Drugs Epigenetics Expatriates Fasting Female Gene expression Gene Expression Profiling Genes Genomes Glucose Humans Insulin Insulin resistance Insulin Resistance - genetics Male Metabolism MicroRNA MicroRNAs MicroRNAs - blood MicroRNAs - genetics Middle Aged Pathophysiology Patients RNA sequencing Transcriptome Type 2 diabetes |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA66IngR366uEkHxFGybtGlOsiyKCHrwAXsrSZroCnbVrgf99c603XXrwVthprTMJPPNJMM3hBzjTZF0PmFKe86EdiFTKrYs0N4YHUMB7fBG9-Y2uXoU18N42By4lU1b5TQmVoE6H1s8Iz_jgLsxxlR1_vbOcGoU3q42IzQWyRJSl2FLlxz-Flw8qoalhYBBLIlVUje-cyjzz0YvryWk8hEgtGxB0t_APIdM7a7JORi6XCOrTf5I-7XD18mCKzbIcj1R8muTXA9mBMzfAEp0MPqw1YAueH7F3ru72z69Hz3VfJ4lHXuKlSiNaNMaU1IIJXguW26Rx8uLh8EVa8YlMCu4nDAAXhuk2jpljLQqUdxCrWZ5xH0aJlrKXMSphj3oVJQaJX1oAgMZj-CR17mXfJt0inHhdgnVPk9zSFWM40ZwrVKtIRPIlTYqVjo1XXIytVj2VrNiZFBNoGWzect2ySmaM8PNAjazuun5h68g7VTWh3gCGZ8QoNlracIit23x1CFZs8nK7HdJdMnRTIxvYuNY4caftU4FwmGX7NT-m_0xV0j2FoMkbXl2poDU221JMXquKLhD5NUMVLD3_3_tk5UI5wUHIQtFj3QmH5_uAJKYiTmsVuoP4gbwhA priority: 102 providerName: ProQuest |
Title | Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39859351 https://www.proquest.com/docview/3159500179 https://www.proquest.com/docview/3159801281 https://pubmed.ncbi.nlm.nih.gov/PMC11766090 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED_tQ6C9oPEdGFWQQDwFktip7QeEumplmrQKDSr1LbIdm3ViKTSdxPjruWs-1ABPvFSRfFaqO9u_38Wn3wG8opsi4fwwUtqziGuXREplNoq1N0ZnmEA7utE9nw5PZ_xsns13oO022jiw-mdqR_2kZqtvb3_-uP2AG_49ZZyYsr9bXF1XSMtTRFuxC_uISYK26Dnv7hOQNmSqLnv_a8YB3GWKVL-ypIdNf57QWxDVL5_cwqPJIdxriGQ4qiN_H3Zc-QDu1K0lbx_C2bhTYv6F6BSOFyu76dSFz9dUhHcxHYWfF19rYc8qXPqQUtIwDZsamSrEM4U-0FaPYDY5-TI-jZq-CZHlTKwjRGAbS22dMkZYNVTMYtJmWcq8TIZaiIJnUuNmdCqVRgmfmNgg9eEs9brwgj2GvXJZuqcQal_IAjmLccxwppXUGilBobRRmdLSBPC69Vj-vZbHyDGtICfn204O4A25M6c4os-sbor_8S2kP5WP8GBB6sc5Wh71LHG12_5wG5C8XSw5Q06WEd6qAF52wzSTKshKt7ypbTZonATwpI5f94_b-Acge5HtDEiDuz9SLi43WtwJCWzGKn72_1Ofw0FKTYXjJEr4EeytVzfuBTKdtRnArpgL_JWTjwPYPz6ZfroYEPZkg83y_g287gMy |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxLMsFDASFSerSZzE8aFCq4Vq-9oDtNLegu3Y7SI1W5qtUPlR_MbO5LHdcODWWyQ7iTWvb8YezwB8pJMi6XzKlfaCx9qFXKnE8kB7Y3SCAbSjE92jSTo-ifenyXQN_nZ3YSitsrOJtaEu5pb2yLcF4m5CNlV9vvjFqWsUna52LTQasThw178xZKt29r4gf7eiaPfr8WjM264C3MZCLjjikw0ybZ0yRlqVKmExpLEiEj4LUy1lESeZRlF1KsqMkj40gUHHIBaR14WXAr97D-4j8AakUXJ6G-CJqG7OFiLm8TRRaZNoL4QKtmc_zysMHSL0CGQPAv8FghUk7GdprsDe7hN43PqrbNgI2FNYc-UzeNB0sLx-DvujZcHnPwiCbDS7tHVDMHw-p1y_b5Mh-z47beqHVmzuGUW-LGJtKk7F0HTRPnD1Ak7uhJAvYb2cl-4VMO2LrEDXyDhhYqFVpjV6HoXSRiVKZ2YAWx3F8oumCkeO0QtRNl-l7AA-ETlzUk6kmdXtHQP8C5W5yodov9DDjGOcudmbiUpl-8MdQ_JWqav8VgQH8GE5TG9Solrp5lfNnBr0wwFsNPxbrlgoKi6X4EjW4-xyApX67o-Us7O65HdIdTwDFbz-_7rew8Px8dFhfrg3OXgDjyLqVRyEPIw3YX1xeeXeogO1MO9qqWXw467V5AbvhCyY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKQFwq3iwUMBIVJ2uTOInjA6pWW1Z9wAoBlfYWbMeGRWq2NFtV5dP4us7ksd1w4NZbpJkk1rzHHs8AvKWTIul8ypX2gsfahVypxPJAe2N0ggm0oxPdT9N0_zg-nCWzDfjb3YWhssrOJtaGulhY2iMfCvS7CdlUNfRtWcTnvcnu6W9OE6TopLUbp9GIyJG7vMD0rXp_sIe83omiyYdv433eThjgNhZyydFX2SDT1iljpFWpEhbTGysi4bMw1VIWcZJpFFunoswo6UMTGAwSYhF5XXgp8Lu34LYUSUg6JmfXyZ6I6kFtIfo_niYqbYruhVDBcP7rpMI0IsLoQPbc4b9OYc0r9is211zg5D5stbErGzXC9gA2XPkQ7jTTLC8fweF41fz5DzpENp6f2Xo4GD6fUN3fl-mIfZ3_aHqJVmzhGWXBLGJtWU7F0IzRnnD1GI5vhJBPYLNclO4ZMO2LrMAwyThhYqFVpjVGIYXSRiVKZ2YAOx3F8tOmI0eOmQxRNl-n7ADeETlzUlSkmdXtfQP8C7W8ykdoyzDajGPE3O5hooLZPrhjSN4qeJVfi-MA3qzA9CYVrZVucd7g1AFAOICnDf9WKxaKGs0lCMl6nF0hUNvvPqSc_6zbf4fU0zNQwfP_r-s13EUFyT8eTI9ewL2IxhYHIQ_jbdhcnp27lxhLLc2rWmgZfL9pLbkC3Uswzg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterizing+Circulating+microRNA+Signatures+of+Type+2+Diabetes+Subtypes&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Sulaiman%2C+Fatima&rft.au=Khyriem%2C+Costerwell&rft.au=Dsouza%2C+Stafny&rft.au=Abdul%2C+Fatima&rft.date=2025-01-14&rft.pub=MDPI&rft.eissn=1422-0067&rft.volume=26&rft.issue=2&rft_id=info:doi/10.3390%2Fijms26020637&rft_id=info%3Apmid%2F39859351&rft.externalDocID=PMC11766090 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |